Table of Contents Author Guidelines Submit a Manuscript
Advances in Orthopedics
Volume 2015, Article ID 428986, 6 pages
http://dx.doi.org/10.1155/2015/428986
Research Article

Low Infection Rate after Tumor Hip Arthroplasty for Metastatic Bone Disease in a Cohort Treated with Extended Antibiotic Prophylaxis

Musculoskeletal Tumor Section, Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark

Received 19 September 2014; Accepted 20 January 2015

Academic Editor: Boris Zelle

Copyright © 2015 Werner H. Hettwer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Jeys, R. J. Grimer, S. R. Carter, and R. M. Tillman, “Periprosthetic infection in patients treated for an orthopaedic oncological condition,” The Journal of Bone and Joint Surgery Series A, vol. 87, no. 4, pp. 842–849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Racano, T. Pazionis, F. Farrokhyar, B. Deheshi, and M. Ghert, “High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review,” Clinical Orthopaedics and Related Research, vol. 471, no. 6, pp. 2017–2027, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Jeys and R. Grimer, “The long-term risks of infection and amputation with limb salvage surgery using endoprostheses,” Recent Results in Cancer Research, vol. 179, pp. 75–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Hernández-Vaquero, M. Fernández-Fairen, A. Torres et al., “Treatment of periprosthetic infections: an economic analysis,” The Scientific World Journal, vol. 2013, Article ID 821650, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Sorensen, K. G. Gregersen, T. Grum-Schwensen, D. Hovgaard, and M. M. Petersen, “Patient and implant survival following joint replacement because of metastatic bone disease: a cross-sectional study of 130 patients with 140 joint replacements,” Acta Orthopaedica, vol. 84, no. 3, pp. 301–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. B. H. Hansen, J. Keller, M. Laitinen et al., “The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities,” Acta Orthopaedica Scandinavica, Supplement, vol. 75, no. 311, pp. 11–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ratasvuori, R. Wedin, J. Keller et al., “Insight opinion to surgically treated metastatic bone disease: scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis,” Surgical Oncology, vol. 22, no. 2, pp. 132–138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Keurentjes, M. Fiocco, B. W. Schreurs, B. G. Pijls, K. A. Nouta, and R. G. Nelissen, “Revision surgery is overestimated in hip replacement,” Bone and Joint Research, vol. 1, no. 10, pp. 258–262, 2012. View at Publisher · View at Google Scholar
  9. Swiss Orthopaedic Society and Swiss Society for Infectious Disease, Infections of the Musculoskeletal System, Swiss Orthopaedic Society, Swiss Society for Infectious Disease, 1st edition, 2014.
  10. Musculoskeletal Tumor Society, Position Statement, 2013, http://msts.org/aboutMSTS/positionStatement.html.
  11. Musculoskeletal Infection Society, International Consensus on Periprosthetic Joint Infection, 2013, http://www.msis-na.org/wp-content/themes/msis-temp/pdf/ism-periprosthetic-joint-information.pdf.
  12. M. Ghert, B. Deheshi, G. Holt et al., “Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study,” British Medical Journal, vol. 2, no. 6, Article ID e002197, 2012. View at Publisher · View at Google Scholar · View at Scopus